0001237899-12-000085.txt : 20121121 0001237899-12-000085.hdr.sgml : 20121121 20121121155036 ACCESSION NUMBER: 0001237899-12-000085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121120 FILED AS OF DATE: 20121121 DATE AS OF CHANGE: 20121121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 121221215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-11-20 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Res and Devel Sciences Common Stock 2012-11-20 4 M 0 17000.0 16.8 A 76121.0 D Common Stock 2012-11-20 4 F 0 1708.0 167.17 D 74413.0 D Common Stock 2012-11-20 4 F 0 7694.0 167.17 D 66719.0 D Common Stock 2012-11-20 4 M 0 37500.0 16.8 A 104219.0 D Common Stock 2012-11-20 4 F 0 3768.0 167.17 D 100451.0 D Common Stock 2012-11-20 4 F 0 16973.0 167.17 D 83478.0 D Common Stock 2012-11-21 4 S 0 9200.0 173.8 D 74278.0 D Common Stock 2012-11-21 4 S 0 13157.0 174.47 D 61121.0 D Common Stock 2012-11-21 4 S 0 2000.0 175.49 D 59121.0 D Common Stock 5479.0 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 16.8 2012-11-20 4 M 0 17000.0 D 2018-12-17 Common Stock 17000.0 52048.0 D Non-Qualified Stock Option (right to buy) 16.8 2012-11-20 4 M 0 37500.0 D 2018-12-17 Common Stock 37500.0 14548.0 D Represents volume-weighted average price of sales of 9,200 shares of Company stock on November 21, 2012 at prices ranging from $173.17 to $173.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 21, 2012 at each separate price. Represents volume-weighted average price of sales of 13,157 shares of Company stock on November 21, 2012 at prices ranging from $174.00 to $174.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 21, 2012 at each separate price. Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 21, 2012 at prices ranging from $175.00 to $175.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 21, 2012 at each separate price. The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**Neil Stahl 2012-11-21